Early research (Phase 1)Looking for participantsNCT05936359
What this trial is testing
Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
Who this might be right for
Myeloproliferative Neoplasms
Incyte Corporation 225